From a technical perspective, LYV is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strongly for the last two months, with shares moving higher from $8.39 to its recent high of $10.12 a share. During that uptrend, shares of LYV have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of LYV within range of triggering a near-term breakout trade.
If you're in the bull camp on LYV, then I would look for long-biased trades if this stock manages to break out above some near-term overhead resistance at $10.12 a share with high volume. Look for a sustained move or close above $10.12 a share with volume that registers near or above its three-month average action of 871,951 shares. If that breakout triggers soon, then LYV will set up to re-test or possibly take out its next major overhead resistance levels at $10.99 to $11.50 a share.
One final name to consider with some decent insider buying is
(NBY - Get Report)
. This is a clinical stage pharmaceutical company engaged in the discovery and development of innovative product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments. Insiders are buying this stock into modest weakness, since shares are off by 10% in the last three months.
Novabay Pharmaceutical has a market cap of $35 million and an enterprise value of $22 million. This stock trades at a fair valuation, with a price-to-sales of 4.86 and a price-to-book of 4.60. Its estimated growth rate for this year is -35%, and for next year it's pegged at 11.1%. This is a cash-rich company, since the total cash position on its balance sheet is $11.88 million and its total debt is zero.
The president and beneficial owner just
bought 120,000 shares, or about $144,000 worth of stock, at $1.20 per share.
From a technical perspective, NBY is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been downtrending badly for the last month, with shares dropping from $1.76 to its recent low of $1.05 a share. During that downtrend, shares of NBY have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of NBY have started to rebound off that $1.05 low and move within range of triggering a near-term breakout trade.